PAR — Par Drugs and Chemicals Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapContrarian

Annual income statement for Par Drugs and Chemicals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Interim Report	ARS	ARS	ARS	ARS
Standards:	—	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	608	751	957	956	1,010
Cost of Revenue
Gross Profit	389	463	293	368	332
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	456	621	808	763	851
Operating Profit	152	130	150	194	159
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	147	127	151	195	179
Provision for Income Taxes
Net Income After Taxes	116	92.1	113	145	134
Net Income Before Extraordinary Items
Net Income	116	92.1	113	145	134
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	116	92.1	113	145	134
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	16.3	7.49	9.12	11.8	10.9
Dividends per Share